share_log
Moomoo 24/7 ·  03/22 09:29

Intellia Therapeutics On March 19, Notified Regeneron Pharmaceuticals That Co Is Opting Out Of Its Factor IX Co-Development And Co-Funding Agreement

Intellia Therapeutics于3月19日通知Regeneron Pharmicals,该公司选择退出其Factor IX共同开发和联合资助协议

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发